Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

1.

Anomalous dopamine release associated with a human dopamine transporter coding variant.

Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD.

J Neurosci. 2008 Jul 9;28(28):7040-6. doi: 10.1523/JNEUROSCI.0473-08.2008.

PMID:
18614672
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Interaction of syntaxin with a single Kv1.1 channel: a possible mechanism for modulating neuronal excitability.

Michaelevski I, Korngreen A, Lotan I.

Pflugers Arch. 2007 Jun;454(3):477-94. Epub 2007 Mar 31.

PMID:
17401576
[PubMed - indexed for MEDLINE]
3.

Behavioral dopamine signals.

Schultz W.

Trends Neurosci. 2007 May;30(5):203-10. Epub 2007 Apr 2. Review.

PMID:
17400301
[PubMed - indexed for MEDLINE]
4.

Distinct modulation of Kv1.2 channel gating by wild type, but not open form, of syntaxin-1A.

Neshatian L, Leung YM, Kang Y, Gao X, Xie H, Tsushima RG, Gaisano HY, Diamant NE.

Am J Physiol Gastrointest Liver Physiol. 2007 May;292(5):G1233-42. Epub 2007 Jan 18.

PMID:
17234891
[PubMed - indexed for MEDLINE]
Free Article
5.

Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism.

Wei Y, Williams JM, Dipace C, Sung U, Javitch JA, Galli A, Saunders C.

Mol Pharmacol. 2007 Mar;71(3):835-42. Epub 2006 Dec 12.

PMID:
17164407
[PubMed - indexed for MEDLINE]
Free Article
6.

Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.

Dipace C, Sung U, Binda F, Blakely RD, Galli A.

Mol Pharmacol. 2007 Jan;71(1):230-9. Epub 2006 Oct 10.

PMID:
17032905
[PubMed - indexed for MEDLINE]
Free Article
7.

Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U.

Neuron. 2006 Aug 17;51(4):417-29.

PMID:
16908408
[PubMed - indexed for MEDLINE]
Free Article
8.

SNAP-25/syntaxin 1A complex functionally modulates neurotransmitter gamma-aminobutyric acid reuptake.

Fan HP, Fan FJ, Bao L, Pei G.

J Biol Chem. 2006 Sep 22;281(38):28174-84. Epub 2006 Jul 21.

PMID:
16861228
[PubMed - indexed for MEDLINE]
Free Article
9.

Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.

Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, Han DD, Gu HH.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9333-8. Epub 2006 Jun 5.

PMID:
16754872
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The role of SNARE proteins in trafficking and function of neurotransmitter transporters.

Quick MW.

Handb Exp Pharmacol. 2006;(175):181-96. Review.

PMID:
16722236
[PubMed - indexed for MEDLINE]
11.

The dopamine transporter proteome.

Torres GE.

J Neurochem. 2006 Apr;97 Suppl 1:3-10. Review.

PMID:
16635244
[PubMed - indexed for MEDLINE]
12.

Abnormally high concentrations of amphetamine in blood of impaired drivers.

Jones AW, Holmgren A.

J Forensic Sci. 2005 Sep;50(5):1215-20.

PMID:
16225234
[PubMed - indexed for MEDLINE]
13.

Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.

Johnson LA, Furman CA, Zhang M, Guptaroy B, Gnegy ME.

Neuropharmacology. 2005 Nov;49(6):750-8. Epub 2005 Oct 5.

PMID:
16212991
[PubMed - indexed for MEDLINE]
14.

Mechanisms of neurotransmitter release by amphetamines: a review.

Sulzer D, Sonders MS, Poulsen NW, Galli A.

Prog Neurobiol. 2005 Apr;75(6):406-33. Review.

PMID:
15955613
[PubMed - indexed for MEDLINE]
15.

Amphetamine induces dopamine efflux through a dopamine transporter channel.

Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A.

Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3495-500. Epub 2005 Feb 22.

PMID:
15728379
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Kv2.1 channel activation and inactivation is influenced by physical interactions of both syntaxin 1A and the syntaxin 1A/soluble N-ethylmaleimide-sensitive factor-25 (t-SNARE) complex with the C terminus of the channel.

Tsuk S, Michaelevski I, Bentley GN, Joho RH, Chikvashvili D, Lotan I.

Mol Pharmacol. 2005 Feb;67(2):480-8. Epub 2004 Nov 3.

PMID:
15525758
[PubMed - indexed for MEDLINE]
Free Article
17.

Plasma membrane targeting of exocytic SNARE proteins.

Sala√ľn C, James DJ, Greaves J, Chamberlain LH.

Biochim Biophys Acta. 2004 Aug 23;1693(2):81-9. Review.

PMID:
15313010
[PubMed - indexed for MEDLINE]
Free Article
18.

Characterization of genetically labeled catecholamine neurons in the mouse retina.

Zhang DQ, Stone JF, Zhou T, Ohta H, McMahon DG.

Neuroreport. 2004 Aug 6;15(11):1761-5.

PMID:
15257143
[PubMed - indexed for MEDLINE]
19.

Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.

Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A.

Mol Pharmacol. 2004 Jul;66(1):137-43.

PMID:
15213305
[PubMed - indexed for MEDLINE]
Free Article
20.

Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter.

Lee KH, Kim MY, Kim DH, Lee YS.

Neurochem Res. 2004 Jul;29(7):1405-9.

PMID:
15202772
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk